GLIS3 and type 2 diabetes mellitus: Interestingly, here we find decreased expression in parallel with increased DNA methylation of several candidate genes for T2D, such as TCF7L2 and GLIS3[51], in palmitate-treated human islets, suggesting that lipid-induced epigenetic modifications may affect the risk for diabetes.